Featured
In Vivo Gene Therapy and CRISPR Cures for Lethal Rare Diseases Move from Lab to Standard Care
In 2026, in vivo gene therapies and CRISPR cures for rare diseases are becoming standard care, highlighted by vision restoration in retinal dystrophie...
Read Full Story →